← Back to Search

Behavioral Intervention

Communication Bridge™ for Primary Progressive Aphasia (CB3_1 Trial)

N/A

Waitlist Available

Led By Emily Roglaski, PhD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

Awards & highlights

CB3_1 Trial Summary

This trial is looking at how well certain treatments work for people with mild to moderate primary progressive aphasia. The treatments focus on improving communication skills.

Who is the study for?

This trial is for adults with mild to moderate primary progressive aphasia (PPA) or related conditions. Participants must speak English, have good enough vision and hearing for daily tasks, be able to use video conferencing and a web app, and not be too depressed based on a scale. Their communication partners also need to meet similar criteria.Check my eligibility

What is being tested?

The study tests the 'Communication Bridge' intervention's effectiveness in improving communication abilities in individuals with PPA. It involves using evidence-based methods delivered through technology like video calls and a specialized web application.See study design

What are the potential side effects?

Since this trial focuses on non-drug interventions involving speech therapy techniques and technology use, traditional medication side effects are not expected. However, participants may experience frustration or fatigue during therapy sessions.

CB3_1 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time frame: 2 assessment time points through study completion, an average of 5 months, including change over time

This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: 2 assessment time points through study completion, an average of 5 months, including change over time for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Communication Participation Person Centered Goals

CB3_1 Trial Design

1Treatment groups

Experimental Treatment

Group I: Communication Bridge™Experimental Treatment1 Intervention

Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor

1,002 Previous Clinical Trials

817,838 Total Patients Enrolled

Western University, CanadaOTHER

239 Previous Clinical Trials

57,471 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,005,102 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals are eligible to participate in this clinical study?

"To be eligible for participation in this trial, candidates must have primary progressive aphasia and fall within the age range of 18 to 100. Around twelve individuals are being sought after for recruitment into this study."

Answered by AI

Are there any available vacancies for patient participation in this clinical trial?

"According to the information available on clinicaltrials.gov, this trial is not currently seeking participants. The initial posting of the trial was made on April 1st, 2024 and it was last updated on January 8th, 2024. However, there are numerous other ongoing trials actively recruiting participants at this time, with a total of 134 studies in progress."

Answered by AI